Cognitive Sequelae in Children Treated for Acute Lymphoblastic Leukemia With Dexamethasone or Prednisone

2000170 citationsJournal Article

Authors

Deborah P. Waber · Boston Children's Hospital

Sarah C. Carpentieri · U.S. National Science Foundation

Neil Klar · U.S. National Science Foundation

Lewis B. Silverman · U.S. National Science Foundation

Molly Schwenn · U.S. National Science Foundation

Craig A. Hurwitz · U.S. National Science Foundation

Phyllis J. Mullenix

Abstract

The findings of this preliminary study are consistent with the hypothesis that dexamethasone therapy can increase risk for neurocognitive late effects in children treated for ALL and indicate that further investigation of this question is warranted.

Topics & Keywords

Acute Lymphoblastic Leukemia research Cancer-related cognitive impairment studies Intensive Care Unit Cognitive Disorders

Publication Details

Published in: The American journal of pediatric hematology/oncology

Volume 22, Issue 3, pp. 206-213

DOI: 10.1097/00043426-200005000-00004

Field-Weighted Citation Impact: 13.21

Command Palette

Cognitive Sequelae in Children Treated for Acute Lymphoblastic Leukemia With Dexamethasone or Prednisone

Authors

Abstract

Topics & Keywords

Publication Details